European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

Improving the customer onboarding experience in an increasingly competitive and congested financial services industry is vital for both legacy banks and those in fintech serious about growth... Guest ...

GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...

GSK reports better-than-expected Q4 earnings. It also announces a new share buyback program and raises the long-term sales outlook for 2031 by $2 billion.

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

The pharmaceutical giant targets an increase in core operating profit of between 6% and 8% in 2025, after cancer treatments ...

Bristol-Myers Squibb (BMY) to announce Q4 earnings on February 6th. Analysts expect $1.47 EPS on $11.56B revenue.

Wall Street was mostly lower on Wednesday despite US employment growth picking up last month by more than expected.

Shares in Google-parent Alphabet (GOOGL, GOOG) tumbled in after-hours trading following the release of the tech giant's ...

Homeowners coming off five-year fixed deals will see their monthly payments rise from £836.07 to £1,111.66 on a typical ...

Also in today’s newsletter, Microsoft poaches DeepMind staff behind AI podcasting feature, and FBI agents sue Trump ...